Pregnancy Clinical Trial
Official title:
Effect of Maternal Rest and Resting Positions on Amniotic Fluid: A Randomized Prospective Study
Maternal rest in left lateral decubitus position increases fetal urine production rate which
in turn increases the estimated amniotic fluid volume (AFV) in uncomplicated pregnancies.
The estimated AFV increases faster at initial periods, particularly during the first, second
and third 15 minute periods of the maternal rest in the left lateral position. Although at
each successive 15 minute period the estimated AFV continues to increase, the increase rate
is always less in the following period. The AFV increase curve resembles the characteristics
of a saturation curve and finally the estimated AFV increase stops approximately at the
second hour.
Although maternal rest in left lateral decubitus position increased the estimated AFV in the
previous studies, the sole effect of left lateral position or the sole effect of rest was
not evaluated, and the results of resting in another position is not known. In addition, it
is hard for a pregnant woman to maintain the left lateral position continuously.
Rest in the prone position is not practical for a pregnant woman, particularly after the
first trimester of the pregnancy and supine position may cause several hypotension related
symptoms including nausea, anxiety, lightheadedness, shortness of breath, perspiration,
tachycardia and urge to change position. Thus, right lateral position may be an alternative.
The purpose of this study is to analyze the effect of maternal rest in the right lateral
decubitus position on estimated amniotic fluid volume in comparison with the left lateral
position. Because, in both groups the mothers rested, our secondary aim was to obtain data
for the contribution of maternal rest to the AFI increase observed in the previous studies.
In order to study the effects of maternal rest in the right or left lateral decubitus
position on amniotic fluid index, the investigators assigned the patients into groups 1 and
2 by using a computerized program and sealed cards (first investigator, K.Ü.). The
department's head nurse used the sealed cards to allocate the participants into groups.
Previous studies detected amniotic fluid index increase during maternal rest in left lateral
decubitus position. Thus, the primary outcome of the study was to detect the same increase
in the left lateral position, and in the right lateral position as an alternative to the
former position. The secondary outcome was to determine the role of resting alone.
The amniotic fluid index change values obtained in a previous study were used to perform
power analysis. Power analysis indicated that in order to achieve an increase from the
initial amniotic fluid index value of 153.76 ± 38.47 to the 15th minute value of 185.42 ±
46.89 with 90% of power at one side alpha of 0.05, at least 34 women were needed in each
group. Thus, 76 women were invited to participate in the study in order to avoid
unpredictable errors.
According to the predefined study design, all participants had an initial AFI measurement.
Following the initial AFI measurements, women in Group 1 ( maternal rest in left lateral
position) rested in the left lateral position for 15 minutes and then rested in the right
lateral position for another 15 minutes. Women in Group 2 (maternal rest in the right
lateral position) started resting in the right lateral position for 15 minutes and then
rested in the left lateral position for another 15 minutes. The AFI values of both groups
were measured before interventions, at the end of first 15 minutes and at the end of second
15 minutes. Depending on the study design it was impractical to blind either the observer or
the participants. The well-being of the fetus and the mother were assessed intermittently by
recording the fetal heart rate trace and measuring the maternal blood pressure and pulse
rate.
In order to avoid the inter-observer variation, a single examiner (Second investigator,
M.Ç.) measured all AFIs by using a high resolution ultrasound apparatus (Voluson 730 Pro;
General Electric-Kretztechnik, Zipf, Austria) equipped with a convex transducer (2-7 MHz)
while the women were on their back in a semi-recumbent position. AFI values were calculated
according to the technique described by Phelan et al.The vertically measured values of the
four amniotic fluid quadrants were added to determine AFI. The same measurement was repeated
immediately and an average of two repetitive measurements determined the AFI. Intra-observer
variations were assessed by using the repetitive AFI measurements.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Completed |
NCT02379728 -
Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth
|
N/A |